Robert Langer, a professor at the Massachusetts Institute of Technology, has become a scientific advisor to Nanobiotix SA in France which is an oncology-focused nanomedicine company. Professor Langer is also a principle investigator at the MIT-Harvard Center for Cancer Nanotechnology Excellence.
